Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,071
Closed -$101K 541
2024
Q1
$101K Sell
19,071
-6,423
-25% -$36.6K ﹤0.01% 424
2023
Q4
$159K Sell
25,494
-56,506
-69% -$234K 0.01% 403
2023
Q3
$392K Buy
82,000
+47,910
+141% +$264K 0.01% 419
2023
Q2
$204K Buy
+34,090
New +$273K ﹤0.01% 481

Other funds holding AFMD

UBS O'Connor's AFMD Position: Q2 2024 in Review

UBS O'Connor sold out of Affimed (AFMD) in Q2 2024, closing a stake of 19,071 shares — an estimated $101K sold.

UBS O'Connor first reported a position in AFMD in Q2 2023 and held it in 4 quarters. The position peaked at $392K in Q3 2023. 44 funds tracked by Wall St. Rank hold AFMD as of Q2 2024.

  • UBS O'Connor reported no remaining Affimed position as of Q2 2024 after selling out during the quarter.
  • UBS O'Connor sold 19,071 Affimed shares in Q2 2024, an estimated $101K.
  • UBS O'Connor first reported a position in Affimed in Q2 2023 and held it in 4 quarters.
  • UBS O'Connor's Affimed position peaked at $392K in Q3 2023.
  • 44 funds tracked by Wall St. Rank held Affimed as of Q2 2024.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.